Associate Professor, Medicine, Tufts Medical Center
Nephrology
Dr. Bertrand L. Jaber, MD
|
|
Give Review
Doctor Bertrand L. Jaber, MD is an expert in the field of Nephrology. He went to St Joseph's University Medical School. He has 1 awards "Fellow (ASNF)". Bertrand L. Jaber, MD is a published doctor and has 100 publications published. The lastest was: 'Understanding Discordant Meta-analyses of Convective Dialytic Therapiesfor Chronic Kidney Failure.' Dr. Bertrand L. Jaber accepts Medicare.
Publications
- Understanding Discordant Meta-analyses of Convective Dialytic Therapies for Chronic Kidney Failure.
- The Daily Burden of Acute Kidney Injury: A Survey of US Nephrologists on World Kidney Day.
- Convective therapies versus low-flux hemodialysis for chronic Kidney failure: a meta-analysis of randomized controlled trials.
- World Incidence of AKI: A Meta-Analysis.
- A meta-analysis of continuous vs intermittent infusion of loop diuretics in hospitalized patients.
- Urinary ?- and ?-glutathione s-transferases for early detection of Acute kidney injury following cardiopulmonary bypass.
- Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic Kidney disease: a meta-analysis.
- Outcome Differences in Community- versus Hospital-Acquired Hyponatremia in Patients with a Diagnosis of Heart Failure.
- AKI Transition of Care: A Potential Opportunity to Detect and Prevent CKD.
- Performance of urinary liver-type fatty acid-binding protein in Acute kidney injury: a meta-analysis.
- Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis.
- Polymorphisms in the myeloperoxidase gene locus are associated with Acute kidney injury-related outcomes.
- GFR at initiation of dialysis and mortality in CKD: a meta-analysis.
- Potential interaction between sevelamer and fat-soluble Vitamins: a hypothesis.
- Molecular adsorbent recirculating system as artificial support therapy for liver Failure: a meta-analysis.
- Therapeutic hypothermia and prevention of Acute kidney injury: a meta-analysis of randomized controlled trials.
- Short-term efficacy and safety of vasopressin receptor antagonists for treatment of hyponatremia.
- Hospital-acquired Acute Kidney Injury: An Analysis of Nadir-to-Peak Serum Creatinine Increments Stratified by Baseline Estimated GFR.
- Filtration markers in Acute kidney injury.
- Off-pump coronary artery bypass surgery and Acute kidney injury: a meta-analysis of randomized controlled trials.
- Plasma cystatin C and Acute kidney injury after cardiopulmonary bypass.
- Impact of hospital-associated hyponatremia on selected outcomes.
- Whole blood transcriptomics in cardiac surgery identifies a gene regulatory network connecting ischemia reperfusion With systemic inflammation.
- Serum cystatin C for prediction of dialysis requirement or death in Acute kidney injury: a comparative study.
- Endotoxin-binding affinity of sevelamer: a potential novel anti-inflammatory mechanism.
- Soluble CD14 and endotoxin levels in hemodialysis patients: a tale of 2 molecules.
- Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal Disease: a review of the evidence.
- Sevelamer hydrochloride use and circulating endotoxin in hemodialysis patients: a pilot cross-sectional study.
- A genetic variant of hypoxia-inducible factor-1alpha is associated with adverse outcomes in Acute kidney injury.
- Epidemiology of hyponatremia.
- Interobserver reliability of urine sediment interpretation.
- KDOQI US commentary on the KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in CKD.
- Multiple organ dysfunction syndrome in children With sepsis: role of genetic factors.
- Timing of renal replacement therapy initiation in Acute renal failure: a meta-analysis.
- Effect of intensive insulin therapy and pentastarch resuscitation on Acute kidney injury in severe sepsis.
- Effect of methyl derivatives of dopamine on tumor necrosis factor alpha and lipid peroxidation.
- Impact of dialyzer membrane on apoptosis and function of polymorphonuclear cells and cytokine synthesis by peripheral blood mononuclear cells in hemodialysis patients.
- Single-use versus reusable dialyzers: the known unknowns.
- Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in Acute renal failure.
- NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in Acute renal failure.
- Incidence and prevalence of hyponatremia.
- Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure.
- Benazepril for advanced Chronic renal insufficiency.
- The serotonin syndrome complicating co-prescription of paroxetine and clarithromycin.
- Long-term management of the tunneled venous catheter.
- Inflammatory biomarkers and cardiovascular risk: association or cause and effect?
- Ultrapure dialysate: facts and myths.
- Dialysis-related amyloidosis: late finding or hidden epidemic?
- Acute renal failure after endovascular vs open repair of abdominal aortic aneurysm.
- Epidemiology and outcomes of Acute renal failure in hospitalized patients: a national survey.
- Progression of chronic Kidney disease: can it be prevented or arrested?
- Immune-modulating effects of melatonin, N-acetylserotonin, and N-acetyldopamine.
- Bacterial infections in hemodialysis patients: pathogenesis and prevention.
- C-reactive protein levels and outcomes after statin therapy.
- Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients.
- Polymorphism of host response genes: implications in the pathogenesis and treatment of Acute renal failure.
- Factors associated with urea reduction ratio in Acute renal failure.
- Iron storage indices: novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy.
- Cytokine gene promoter polymorphisms and mortality in Acute renal failure.
- Rationale and experience With short daily hemofiltration.
- Predicting treatment dose for novel therapies using urea standard Kt/V.
- Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic Kidney disease: a meta-analysis of randomized, controlled trials.
- Dialysis membrane and modality in Acute renal failure: understanding discordant meta-analyses.
- Anemia in Acute renal failure: role for erythropoiesis-stimulating proteins?
- Soluble Fas: a novel marker of inflammation in uremia.
- Update on dialytic management of Acute renal failure.
- A time for rediscovery: Chronic hemofiltration for end-stage renal disease.
- Effect of a novel adsorbent on cytokine responsiveness to uremic plasma.
- Hemodialysis-associated methemoglobinemia in Acute renal failure.
- C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway.
- Difficulty in breathing With decreased urine output in São Paulo, Brazil.
- Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances.
- Exploration of disease mechanism in Acute kidney injury using a multiplex bead array assay: a nested case-control pilot study.
- Utilization and outcome of ''out-of-center hemodialysis'' in the United States: a contemporary analysis.
- Interleukin-8 and Acute kidney injury following cardiopulmonary bypass: a prospective cohort study.
- Phenylethanolamine N-methyltransferase gene polymorphisms and adverse outcomes in Acute kidney injury.
- Effect of intra-dialytic, low-intensity strength training on functional capacity in adult haemodialysis patients: a randomized pilot trial.
- Renal replacement therapy for Acute kidney injury.
- Comparative analysis of urinary biomarkers for early detection of Acute kidney injury following cardiopulmonary bypass.
- Dialysis: Some patients may benefit from using high-flux membranes.
- Iron storage indices and risk of bacterial infections in hemodialysis patients.
- Scope and design of the Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements (FREEDOM) Study.
- Mitochondrial DNA injury and mortality in hemodialysis patients.
- Protective effect of erythropoietin against radiocontrast-induced Renal tubular epithelial cell injury.
- Plasma adiponectin levels and clinical outcomes among haemodialysis patients.
- Endotoxin-binding affinity of sevelamer hydrochloride.
- A systematic review of the effect of the Excebrane dialyser on biomarkers of lipid peroxidation.
- Gene polymorphism association studies in dialysis: cardiovascular Disease.
- Relationship of urine output to dialysis initiation and mortality in Acute renal failure.
- Genomic medicine, gene polymorphisms, and human biological diversity.
- Model for gene-environment interaction: the case for dialysis.
- Transforming growth factor-beta 1 gene polymorphisms and cardiovascular Disease in hemodialysis patients.
- Reprocessed (high-flux) Polyflux dialyzers resist trans-membrane endotoxin passage and attenuate inflammatory markers.
- Cytokine single nucleotide polymorphism. Role in Acute renal failure.
- Daily hemofiltration for end-stage renal Disease: a feasibility and efficacy trial.
- Cytokine gene polymorphisms in hemodialysis patients: association With comorbidity, functionality, and serum albumin.
- Dialyzer membrane type and reuse practice influence polymorphonuclear leukocyte function in hemodialysis patients.
- Polymorphism of immunomodulatory cytokine genes: implications in Acute renal failure.
- Antioxidant and oxidative stress indices in dialysis-dependent Acute renal failure.
Schools
Faculte Francaise De Medecine Et De Pharmacie
Carney Hospital
New England Med Center
Procedures Preformed
- End-Stage Renal Disease Related Services
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acute Kidney Failure
- Chronic Kidney Diseases
- Congenital Cystic Kidney Disease
- Congenital Polycystic Kidney Disease
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Emblem Health
- First Health (Coventry Health Care) PPO
- Harvard Pilgrim Health Care PPO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Tufts Health Plans
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Fellow (ASNF)
Education
-
Tufts Medical Center -
St Joseph's University Medical School
Drug Facts
| NPI NUMBER | 1588659445 | |
| NPPES Provider LastName | JABER | |
| NPPES Provider FirstName | BERTRAND | |
| NPPES Provider ZIPCode | 02135 | |
| NPPES Provider State | MA | |
| Specialty Description | Nephrology | |
| Total Claim Count | 522.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1588659445 |
| Last Name Of The Provider | JABER |
| First Name Of The Provider | BERTRAND |
| View All |
Similar Doctors
|
|
Dr. Tejas V. Patel, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sebastian A. Varas Garcia, MD |
|
|
Dr. Nitender Goyal, MD |
|
|
Dr. Abraham B. Cohen, MD |
|
|
Dr. Mohamed Y. Alseiari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicolaos E. Madias, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Geetha Narayan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martin L. Gelman, MD
This Doctor is OpenDoctor Recommended.
|